The Perelman School of Medicine’s J. Joseph Melenhorst authored a study on the effects of CAR T cells on the treatment of chronic lymphocytic leukemia. Since receiving the modified T cells, the patient has been cancer-free for five years.

May 30, 2018 ・ From PhillyVoice